메뉴 건너뛰기




Volumn 62, Issue 3, 2011, Pages 178-188

Health services research the example of atopic dermatitis;Versorgungsforschung am beispiel neurodermitis

Author keywords

Atopic dermatitis; Health services research; Prevalence; Secondary data analysis; Therapy

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; PREDNISOLONE;

EID: 79955574632     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-010-2079-4     Document Type: Review
Times cited : (7)

References (30)
  • 1
    • 33746509201 scopus 로고    scopus 로고
    • Health care research: The last mile in sight
    • Pfaff H (2006) Health care research: the last mile in sight. Dtsch Med Wochenschr 131:1488-1490
    • (2006) Dtsch Med Wochenschr , vol.131 , pp. 1488-1490
    • Pfaff, H.1
  • 3
    • 65049087034 scopus 로고    scopus 로고
    • Significance of atopic dermatitis in outpatient medical care. Analysis of health care data from Saxony
    • Schmitt J, Schmitt NM, Kirch W, Meurer M (2009) Significance of atopic dermatitis in outpatient medical care. Analysis of health care data from Saxony. Hautarzt 60:320-327
    • (2009) Hautarzt , vol.60 , pp. 320-327
    • Schmitt, J.1    Schmitt, N.M.2    Kirch, W.3    Meurer, M.4
  • 4
    • 64249114480 scopus 로고    scopus 로고
    • Outpatient care and medical treatment of children and adults with atopic eczema
    • Schmitt J, Schmitt NM, Kirch W, Meurer M (2009) Outpatient care and medical treatment of children and adults with atopic eczema. J Dtsch Dermatol Ges 7:345-351
    • (2009) J Dtsch Dermatol Ges , vol.7 , pp. 345-351
    • Schmitt, J.1    Schmitt, N.M.2    Kirch, W.3    Meurer, M.4
  • 5
    • 70349922905 scopus 로고    scopus 로고
    • Auswirkungen der Einführung der Praxisgebühr auf die ambulante Versorgung und Therapie des atopischen Ekzems
    • Schmitt J, Kirch W, Meurer M (2009) Auswirkungen der Einführung der Praxisgebühr auf die ambulante Versorgung und Therapie des atopischen Ekzems. J Dtsch Dermatol Ges 7(10):879-886
    • (2009) J Dtsch Dermatol Ges , vol.7 , Issue.10 , pp. 879-886
    • Schmitt, J.1    Kirch, W.2    Meurer, M.3
  • 7
    • 33847240690 scopus 로고    scopus 로고
    • Systemic treatment of severe atopic eczema: A systematic review
    • DOI 10.2340/00015555-0207
    • Schmitt J, Schakel K, Schmitt N, Meurer M (2007) Systemic treatment of severe atopic eczema: a systematic review. Acta Derm Venereol 87:100-111 (Pubitemid 46521989)
    • (2007) Acta Dermato-Venereologica , vol.87 , Issue.2 , pp. 100-111
    • Schmitt, J.1    Schakel, K.2    Schmitt, N.3    Meurer, M.4
  • 8
    • 34250337259 scopus 로고    scopus 로고
    • Cyclosporin in the treatment of patients with atopic eczema - A systematic review and meta-analysis
    • DOI 10.1111/j.1468-3083.2006.02023.x
    • Schmitt J, Schmitt NM, Meurer M (2007) Cyclosporin in the treatment of patients with atopic eczema - a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 21:606-619 (Pubitemid 46916758)
    • (2007) Journal of the European Academy of Dermatology and Venereology , vol.21 , Issue.5 , pp. 606-619
    • Schmitt, J.1    Schmitt, N.2    Meurer, M.3
  • 9
    • 0030027092 scopus 로고    scopus 로고
    • Evidence based medicine: What it is and what it isn't
    • Sackett DL, Rosenberg WM, Gray JA et al (1996) Evidence based medicine: what it is and what it isn't. BMJ 312:71-72
    • (1996) BMJ , vol.312 , pp. 71-72
    • Sackett, D.L.1    Rosenberg, W.M.2    Gray, J.A.3
  • 10
    • 76949095922 scopus 로고    scopus 로고
    • Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial
    • Schmitt J, Schakel K, Folster-Holst R et al (2009) Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial. Br J Dermatol 162(3):661-668
    • (2009) Br J Dermatol , vol.162 , Issue.3 , pp. 661-668
    • Schmitt, J.1    Schakel, K.2    Folster-Holst, R.3
  • 12
    • 19644366045 scopus 로고    scopus 로고
    • Clinical practice. Atopic dermatitis
    • Williams HC (2005) Clinical practice. Atopic dermatitis. N Engl J Med 352:2314-2324
    • (2005) N Engl J Med , vol.352 , pp. 2314-2324
    • Williams, H.C.1
  • 13
    • 38349084979 scopus 로고    scopus 로고
    • Assessment of health state utilities of controlled and uncontrolled psoriasis and atopic eczema - A population-based study
    • Schmitt J, Meurer M, Klon M, Frick KD (2007) Assessment of health state utilities of controlled and uncontrolled psoriasis and atopic eczema - a population-based study. Br J Dermatol 158:351-359
    • (2007) Br J Dermatol , vol.158 , pp. 351-359
    • Schmitt, J.1    Meurer, M.2    Klon, M.3    Frick, K.D.4
  • 14
    • 24044465523 scopus 로고    scopus 로고
    • Therapeutischer Nutzen in der dermatologischen Behandlung
    • Zschocke I, Hammelmann U, Augustin M (2005) Therapeutischer Nutzen in der dermatologischen Behandlung. Hautarzt 56:839-846
    • (2005) Hautarzt , vol.56 , pp. 839-846
    • Zschocke, I.1    Hammelmann, U.2    Augustin, M.3
  • 15
  • 16
    • 0036595910 scopus 로고    scopus 로고
    • Perceptions of physicians and pediatric patients about atopic dermatitis, its impact, and its treatment
    • Paller AS, McAlister RO, Doyle JJ, Jackson A (2002) Perceptions of physicians and pediatric patients about atopic dermatitis, its impact, and its treatment. Clin Pediatr (Phila) 41:323-332 (Pubitemid 34633835)
    • (2002) Clinical Pediatrics , vol.41 , Issue.5 , pp. 323-332
    • Paller, A.S.1    Mcalister, R.O.2    Doyle, J.J.3    Jackson, A.4
  • 17
    • 33751566656 scopus 로고    scopus 로고
    • Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: An analysis of third-party managed care claims data
    • DOI 10.1016/j.clinthera.2006.10.004, PII S014929180600244X
    • Lee WC, Balu S, Cobden D et al (2006) Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther 28:1712-1725 (Pubitemid 44841979)
    • (2006) Clinical Therapeutics , vol.28 , Issue.10 , pp. 1712-1725
    • Lee, W.C.1    Balu, S.2    Cobden, D.3    Joshi, A.V.4    Pashos, C.L.5
  • 19
    • 34250805302 scopus 로고    scopus 로고
    • Role of depression in quality of life for patients with psoriasis
    • DOI 10.1159/000102029
    • Schmitt JM, Ford DE (2007) Role of depression in quality of life for patients with psoriasis. Dermatology 215:17-27 (Pubitemid 46976010)
    • (2007) Dermatology , vol.215 , Issue.1 , pp. 17-27
    • Schmitt, J.M.1    Ford, D.E.2
  • 20
    • 44349109538 scopus 로고    scopus 로고
    • Determinants of treatment goals and satisfaction of patients with atopic eczema
    • Schmitt J, Csotonyi F, Bauer A, Meurer M (2008) Determinants of treatment goals and satisfaction of patients with atopic eczema. J Dtsch Dermatol Ges 6:458-466
    • (2008) J Dtsch Dermatol Ges , vol.6 , pp. 458-466
    • Schmitt, J.1    Csotonyi, F.2    Bauer, A.3    Meurer, M.4
  • 21
    • 36749100164 scopus 로고    scopus 로고
    • What are the best outcome measurements for atopic eczema? A systematic review
    • DOI 10.1016/j.jaci.2007.08.011, PII S0091674907015746
    • Schmitt J, Langan SM, Williams HC (2007) What are the best outcome measurements for atopic eczema? - A systematic review. J Allergy Clin Immunol 120:1389-1398 (Pubitemid 350216596)
    • (2007) Journal of Allergy and Clinical Immunology , vol.120 , Issue.6 , pp. 1389-1398
    • Schmitt, J.1    Langan, S.2    Williams, H.C.3
  • 22
    • 37749041179 scopus 로고    scopus 로고
    • OMERACT: An international initiative to improve outcome measurement in rheumatology
    • Tugwell P, Boers M, Brooks P et al (2007) OMERACT: an international initiative to improve outcome measurement in rheumatology. Trials 8:38
    • (2007) Trials , vol.8 , pp. 38
    • Tugwell, P.1    Boers, M.2    Brooks, P.3
  • 23
    • 79951510545 scopus 로고    scopus 로고
    • Core outcome domains for controlled trials and clinical recordkeeping in eczema: International multi-perspective Delphi consensus process
    • published online Oct 14, 2010
    • Schmitt J, Langan S, Stamm T, Williams HC (2010) Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multi-perspective Delphi consensus process. J Invest Dermatol (published online Oct 14, 2010)
    • (2010) J Invest Dermatol
    • Schmitt, J.1    Langan, S.2    Stamm, T.3    Williams, H.C.4
  • 24
    • 70349331687 scopus 로고    scopus 로고
    • Psychiatric comorbidity in adult eczema
    • Schmitt J, Romanos M, Pfennig A et al (2009) Psychiatric comorbidity in adult eczema. Br J Dermatol 161:878-883
    • (2009) Br J Dermatol , vol.161 , pp. 878-883
    • Schmitt, J.1    Romanos, M.2    Pfennig, A.3
  • 25
    • 60749097993 scopus 로고    scopus 로고
    • Atopic eczema and attention-deficit/hyperactivity disorder in a population-based sample of children and adolescents
    • Schmitt J, Romanos M, Schmitt NM et al (2009) Atopic eczema and attention-deficit/hyperactivity disorder in a population-based sample of children and adolescents. JAMA 301:724-726
    • (2009) JAMA , vol.301 , pp. 724-726
    • Schmitt, J.1    Romanos, M.2    Schmitt, N.M.3
  • 26
    • 77649335026 scopus 로고    scopus 로고
    • Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sample
    • Romanos M, Gerlach M, Warnke A, Schmitt J (2010) Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sample. J Epidemiol Community Health 64:269-273
    • (2010) J Epidemiol Community Health , vol.64 , pp. 269-273
    • Romanos, M.1    Gerlach, M.2    Warnke, A.3    Schmitt, J.4
  • 27
    • 78349290405 scopus 로고    scopus 로고
    • Is atopic disease a risk factor for attention-deficit/hyperactivity disorder? A systematic review
    • Schmitt J, Buske-Kirschbaum A, Roessner V (2010) Is atopic disease a risk factor for attention-deficit/hyperactivity disorder? A systematic review. Allergy 65(12):1506-1524
    • (2010) Allergy , vol.65 , Issue.12 , pp. 1506-1524
    • Schmitt, J.1    Buske-Kirschbaum, A.2    Roessner, V.3
  • 28
    • 75849133892 scopus 로고    scopus 로고
    • Infant-onset eczema in relation to mental health problems at age 10 years: Results from a prospective birth cohort study (German Infant Nutrition Intervention plus)
    • Schmitt J, Apfelbacher C, Chen CM et al (2010) Infant-onset eczema in relation to mental health problems at age 10 years: results from a prospective birth cohort study (German Infant Nutrition Intervention plus). J Allergy Clin Immunol 125:404-410
    • (2010) J Allergy Clin Immunol , vol.125 , pp. 404-410
    • Schmitt, J.1    Apfelbacher, C.2    Chen, C.M.3
  • 29
    • 79955583607 scopus 로고    scopus 로고
    • Infant eczema, infant sleeping problems and mental health at age 10 years: The prospective birth-cohort study LISAplus
    • published online Sept 29, 2010
    • Schmitt J, Chen CM, Apfelbacher C et al (2010) Infant eczema, infant sleeping problems and mental health at age 10 years: The prospective birth-cohort study LISAplus. Allergy (published online Sept 29, 2010)
    • (2010) Allergy
    • Schmitt, J.1    Chen, C.M.2    Apfelbacher, C.3
  • 30
    • 0032078348 scopus 로고    scopus 로고
    • Altered reactivity of the hypothalamus-pituitary-adrenal axis in patients with atopic dermatitis: Pathologic factor or symptom?
    • Buske-Kirschbaum A, Jobst S, Hellhammer DH (1998) Altered reactivity of the hypothalamus-pituitary-adrenal axis in patients with atopic dermatitis: pathologic factor or symptom? Ann N Y Acad Sci 840:747-754
    • (1998) Ann N Y Acad Sci , vol.840 , pp. 747-754
    • Buske-Kirschbaum, A.1    Jobst, S.2    Hellhammer, D.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.